|
2017
|
Invention
|
Treatment of cognitive disorders with (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carbox... |
|
2016
|
Invention
|
Crystalline form of (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochlorid... |
|
|
Invention
|
Aminoisoxazoline compounds as agonists of alpha7-nicotinic acetylcholine receptors.
The present ... |
|
|
Invention
|
Oxadiazine compounds and methods of use thereof. The present disclosure relates to oxadiazine com... |
|
|
Invention
|
Aminobenzisoxazole compounds as agonists of a7-nicotinic acetylcholine receptors. The present inv... |
|
|
Invention
|
Methods for treating cognitive disorders using inhibitors of histone deacetylase.
This disclosur... |
|
2015
|
Invention
|
Dibenzo[b,f][1,4]oxazepin-11-yl-n-hydroxybenzamides as hdac inhibitors.
This invention relates t... |
|
|
Invention
|
Fused morpholinopyrimidines and methods of use thereof. The present disclosure relates to Fused M... |
|
2014
|
Invention
|
5- and 6-membered heterocyclic compounds.
5- and 6-membered heterocyclic compounds which are inh... |
|
|
Invention
|
Phenoxymethyl heterocyclic compounds.
Phenoxymethyl compounds that inhibit at least one phosphod... |
|
|
Invention
|
Fused morpholinopyrimidines and methods of use thereof. The present invention relates to Fused Mo... |
|
|
Invention
|
Fused morphlinopyrimidines and methods of use thereof. The present invention relates to Fused Mor... |
|
|
Invention
|
1,2-disubstituted heterocyclic compounds. 1,2-disubstituted heterocyclic compounds which are inhi... |
|
|
Invention
|
Spiro-oxadiazoline compounds as agonists of α-7-nicotinic acetylcholine receptors. The present in... |
|
|
G/S
|
Pharmaceuticals and biopharmaceutical preparations; diagnostic agents, preparations and substance... |
|
|
Invention
|
Treatment of cognitive disorders with certain alpha-7 nicotinic acid receptors in combination wit... |
|
|
Invention
|
Polymorphs and salts of a compound. Disclosed are novel crystalline polymorphic forms of 4-(4-(im... |
|
2013
|
Invention
|
Methods of maintaining, treating or improving cognitive function. A method of administering an ef... |
|
|
Invention
|
Dibenzo[b,f][1,4]oxazepin-11-yl-n-hydroxybenzamides as hdac inhibitors. This invention relates to... |
|
2012
|
Invention
|
Phenoxymethyl heterocyclic compounds. Phenoxymethyl compounds that inhibit at least one phosphodi... |
|
|
Invention
|
Methods of treatment of limited cognitive impairment.
A method for improving or treating a Limit... |
|
|
Invention
|
Treatment of cognitive disorders with certain alpha-7 nicotinic acid receptor agonists in combina... |
|
|
Invention
|
Methods of targeted treatment of frontotemporal lobar degeneration.
The present invention provid... |
|
|
Invention
|
Methods of targeted treatment of frontotemporal lobar degeneration. The present invention provide... |
|
2011
|
Invention
|
Treatment of inflammation with certain alpha-7 nicotinic acid receptor agonists in combination wi... |
|
|
Invention
|
A crystalline form of (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochlor... |
|
2009
|
Invention
|
5- and 6-membered heterocyclic compounds. 5- and 6-membered heterocyclic compounds which are inhi... |
